Concentrix Corporation

As of May 31, 2026, Concentrix Corporation carries a market capitalization of 1.48B, placing it among publicly traded companies globally. Its enterprise value stands at 5.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Concentrix Corporation's next confirmed earnings release is scheduled for January 19, 2027.

As of May 31, 2026, Concentrix Corporation has 60.86M shares outstanding.

These figures are as of May 31, 2026. The price-to-sales ratio is 0.17, and the price-to-book ratio stands at 0.64.

These figures are as of May 31, 2026. The EV/Sales ratio of 0.60 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.19B versus a market cap of 1.48B, with the gap driven by net debt and cash on the balance sheet.

As of May 31, 2026, Concentrix Corporation maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 169.73, indicating elevated leverage, while an interest coverage ratio of -1.29 demonstrates limited ability to service its debt obligations.

Over the twelve months ended May 31, 2026, Concentrix Corporation posted a negative return on equity (ROE) of -37.66, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.48, reflecting losses generated across the asset base. The company generates approximately 18,902.87 in revenue per employee across its workforce of 453,750.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended May 31, 2026, Concentrix Corporation recorded 66.81M in income tax expense. The company reported a pretax loss of -1.06B and -1.13B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Concentrix Corporation's stock has declined approximately 25.17% over the past 52 weeks. The 50-day moving average sits at 22.60, while the 200-day moving average is 26.56.

Over the twelve months ended May 31, 2026, Concentrix Corporation generated 8.58B in revenue and converted that into -1.13B in net income, yielding earnings per share of -18.26. EBITDA reached -315.26M, while operating income came in at 434.31M.

As of May 31, 2026, Concentrix Corporation holds 219.22M in cash and equivalents against 3.93B in total debt, resulting in a net debt position of 3.71B. Total book value stands at 2.32B, with working capital of 395.03M providing operational flexibility.

Concentrix Corporation produced 637.94M in operating cash flow over the twelve months ended May 31, 2026. After subtracting -197.43M in capital expenditures, free cash flow totaled 440.51M - equivalent to 7.14 per share.

Over the twelve months ended May 31, 2026, Concentrix Corporation posted a gross margin of 34.04, reflecting its pricing power and cost economics. The operating margin of 5.06 and net profit margin of -13.15 provide insight into operational efficiency.

Over the twelve months ended May 31, 2026, Concentrix Corporation paid dividends of 1.27 per share. The dividend payout ratio of -6.95 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 29.44, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 36.06, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Concentrix Corporation shareholders.

As of May 31, 2026, Concentrix Corporation has an Altman Z-Score of 2.48, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.